Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LIV by WellNow vs Medsol RX

LIV by WellNow
Graded #262

Higher grade

vs+1.8999999999999986
Medsol RX
Graded #306

Lower grade

The verdict

LIV by WellNow takes it — 62.9/100 to 61/100, but only just.

LIV by WellNow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide for weight loss. Medsol RX is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLIV by WellNow +6
51
45
Dose & formulationLIV by WellNow +9
73
64
Clinical oversightEven
79
79
Labs & monitoringMedsol RX +1
52
53
FulfillmentMedsol RX +20
63
83
Contract termsLIV by WellNow +14
55
41
LIV by WellNow · left barMedsol RX · right bar

The numbers

MetricLIV by WellNowMedsol RX
WeighScore62.9/10061/100
GradeCC
Scorecard rank#262#306
Semaglutide$279/mo$209/mo (compounded)
TirzepatideNot disclosed$250/mo (compounded)
Coverage5 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
LIV by WellNow

Graded #262 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide
Medsol RX

Graded #306 · C

Strengths

  • Compounded semaglutide from $209/mo (12-mo plan) and tirzepatide from ~$250/mo; HSA/FSA eligible with Klarna financing
  • Every plan bundles the medication, a dedicated care coach, custom treatment plan, medical oversight, and free shipping
  • Board-certified clinicians via OpenLoop; same-day approvals; ships nationwide
  • Month-to-month option ($199 first month) with no long-term commitment, plus microdosing and wellness add-ons

Where it loses points

  • Doesn't name its compounding pharmacy (generic 'certified U.S. pharmacies')
  • No legal entity name published on the site
  • Tirzepatide pricing is given as a range ($250-$1,400/mo), not a fixed rate
  • Compounded GLP-1s are not FDA-approved (the site discloses this)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard